Autocamtide-2-related inhibitory peptide TFA

Autocamtide-2-related inhibitory peptide TFA is a synthetic peptide inhibitor designed to selectively target and modulate the activity of calcium/calmodulin-dependent protein kinase II (CaMKII). Structurally derived from the autocamtide-2 sequence, this peptide incorporates specific amino acid residues that confer high affinity and specificity for the CaMKII catalytic domain, enabling potent and reversible inhibition in biochemical assays. Its trifluoroacetate (TFA) salt form ensures enhanced solubility and stability, making it particularly suitable for a range of in vitro experimental systems. As a research tool, Autocamtide-2-related inhibitory peptide TFA is widely recognized for its utility in dissecting CaMKII-mediated signaling pathways, which are central to numerous physiological and cellular processes.

Kinase inhibition studies: As a highly selective inhibitor of CaMKII, this peptide is extensively employed in kinase activity assays to elucidate the functional roles of CaMKII in diverse signaling cascades. Researchers utilize it to achieve precise temporal and spatial control over kinase activity, enabling the assessment of downstream phosphorylation events and the mapping of CaMKII-dependent signaling networks. Its use is particularly valuable for distinguishing CaMKII-specific effects from those mediated by other serine/threonine kinases, thus facilitating the accurate interpretation of experimental outcomes in cellular and biochemical contexts.

Signal transduction research: The peptide serves as a critical tool in studies investigating calcium/calmodulin signaling pathways, especially those involving synaptic plasticity, gene expression, and cytoskeletal dynamics. By selectively inhibiting CaMKII, it allows researchers to probe the mechanistic links between calcium influx, calmodulin activation, and subsequent cellular responses. This targeted approach aids in unraveling the molecular underpinnings of neuronal communication, memory formation, and other calcium-dependent physiological processes.

Peptide-based assay development: The well-characterized inhibitory profile and specificity of Autocamtide-2-related inhibitory peptide TFA make it a valuable component in the development and validation of in vitro kinase assays. It is frequently incorporated into assay platforms to establish negative controls, benchmark inhibitor potency, or calibrate system sensitivity. Such applications are essential for high-throughput screening, drug discovery, and the quantitative analysis of kinase activity in complex biological samples.

Protein-protein interaction studies: By modulating CaMKII activity, the peptide provides a means to investigate the dynamic interactions between CaMKII and its substrates or regulatory partners. Researchers employ it to dissect the contribution of kinase-mediated phosphorylation events to protein complex assembly, subcellular localization, and functional modulation. These studies yield insights into the structural and regulatory mechanisms governing signal transduction networks, supporting advancements in cellular biochemistry and molecular pharmacology.

Cellular pathway dissection: In cultured cell models and cell-free systems, the peptide is used to selectively inhibit CaMKII activity, thereby enabling the dissection of its role in various cellular pathways. Its application facilitates the identification of CaMKII-dependent processes, such as cytoskeletal remodeling, vesicle trafficking, and transcriptional regulation. By providing a reversible and specific means of kinase inhibition, the peptide supports the systematic analysis of pathway architecture, feedback mechanisms, and cross-talk with other signaling modules.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors